Differential	differential	NN	O
scanning	scanning	NN	O
fluorimetry	fluorimetry	NN	O
,	,	,	O
also	also	RB	O
termed	term	VBD	O
thermal	thermal	JJ	O
shift	shift	NN	O
assay	assay	NNP	O
,	,	,	O
is	be	VBZ	O
an	an	DT	O
efficient	efficient	JJ	O
technique	technique	NN	O
for	for	IN	O
direct	direct	JJ	O
determination	determination	NN	O
of	of	IN	O
a	a	DT	O
small	small	JJ	O
moleculeâs	moleculeâs	CD	O
affinity	affinity	NN	O
to	to	IN	O
a	a	DT	O
protein	protein	NN	O
target	target	NN	B
.	.	.	O

The	the	DT	O
underlying	underlie	VBG	O
principle	principle	NN	O
of	of	IN	O
the	the	DT	O
method	method	NN	O
is	be	VBZ	O
the	the	DT	O
ability	ability	NN	O
of	of	IN	O
a	a	DT	O
small	small	JJ	O
molecule	molecule	NN	O
binding	bind	VBG	O
to	to	IN	O
the	the	DT	O
protein	protein	NN	O
,	,	,	O
in	in	IN	O
principle	principle	NN	O
,	,	,	O
to	to	TO	O
stabilise	stabilise	VB	O
or	or	CC	O
destabilise	destabilise	VB	O
the	the	DT	O
tertiary	tertiary	JJ	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
macromolecule	macromolecule	NN	O
and	and	CC	O
thus	thus	RB	O
increase	increase	VB	O
or	or	CC	O
decrease	decrease	VB	O
its	-PRON-	PRP$	O
melting	melt	VBG	O
temperature	temperature	NN	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Earlier	early	RBR	O
,	,	,	O
we	-PRON-	PRP	O
conducted	conduct	VBD	O
a	a	DT	O
high	high	JJ	O
-	-	HYPH	O
throughput	throughput	NN	O
DSF	DSF	NNP	O
screening	screening	NN	O
of	of	IN	O
a	a	DT	O
chemically	chemically	RB	O
diverse	diverse	JJ	O
set	set	NN	O
of	of	IN	O
8000	8000	CD	O
compounds	compound	NNS	O
selected	select	VBN	O
from	from	IN	O
the	the	DT	O
Enamine	Enamine	NNP	O
screening	screening	NN	O
collection	collection	NN	O
comprising	comprise	VBG	O
over	over	IN	O
2,000,000	2,000,000	CD	O
compounds	compound	NNS	B
against	against	IN	O
bovine	bovine	NNP	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
,	,	,	O
a	a	DT	O
protein	protein	NN	O
most	most	RBS	O
closely	closely	RB	O
resembling	resemble	VBG	O
isoform	isoform	NN	O
II	II	NNP	O
of	of	IN	O
the	the	DT	O
human	human	JJ	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
.	.	.	O

This	this	DT	O
led	lead	VBD	O
to	to	IN	O
the	the	DT	O
discovery	discovery	NN	O
of	of	IN	O
three	three	CD	O
compounds	compound	NNS	O
1â3	1â3	NNP	O
that	that	WDT	O
produced	produce	VBD	O
noticeable	noticeable	JJ	O
thermal	thermal	JJ	O
shift	shift	NN	O
of	of	IN	O
bCA	bCA	NNP	O
Tm	Tm	NNP	O
ÎTm	ÎTm	NNP	O
which	which	WDT	O
did	do	VBD	O
not	not	RB	O
belong	belong	VB	O
to	to	IN	O
any	any	DT	O
of	of	IN	O
then	then	RB	O
-	-	HYPH	O
known	know	VBN	O
classes	class	NNS	O
of	of	IN	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
inhibitors	inhibitor	NNS	O
and	and	CC	O
which	which	WDT	O
we	-PRON-	PRP	O
dubbed	dub	VBD	O
as	as	IN	O
Strecker	Strecker	NNP	O
Î±-aminonitriles	î±-aminonitrile	VBZ	O
considering	consider	VBG	O
they	-PRON-	PRP	O
could	could	MD	O
be	be	VB	O
obtained	obtain	VBN	O
from	from	IN	O
various	various	JJ	O
ketones	ketone	NNS	O
via	via	IN	O
the	the	DT	O
Strecker	Strecker	NNP	O
reaction	reaction	NN	O
.	.	.	O

Besides	besides	IN	O
the	the	DT	O
TSA	TSA	NNP	O
biophysical	biophysical	JJ	O
readout	readout	NN	O
,	,	,	O
these	these	DT	O
compounds	compound	NNS	O
were	be	VBD	O
found	find	VBN	O
,	,	,	O
by	by	IN	O
testing	testing	NN	O
in	in	IN	O
biochemical	biochemical	NNP	O
stopped	stop	VBN	O
-	-	HYPH	O
flow	flow	NN	O
kinetics	kinetic	NNS	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
assay	assay	NN	O
,	,	,	O
to	to	TO	O
inhibit	inhibit	VB	O
hCA	hCA	NNP	O
II	II	NNP	O
in	in	IN	O
the	the	DT	O
single	single	JJ	O
-	-	HYPH	O
digit	digit	NN	O
micromolar	micromolar	JJ	O
range	range	NN	B
.	.	.	O

Strecker	strecker	NN	O
Î±-aminonitrile	Î±-aminonitrile	NNP	O
hCA	hCA	VBD	O
II	II	NNP	O
inhibitory	inhibitory	NN	O
hits	hit	VBZ	O
1â3	1â3	CD	O
discovered	discover	VBD	O
earlier	early	RBR	O
via	via	IN	O
the	the	DT	O
DSF	DSF	NNP	O
screening	screening	NN	O
.	.	.	O

As	as	IN	O
it	-PRON-	PRP	O
was	be	VBD	O
confirmed	confirm	VBN	O
that	that	IN	O
compounds	compound	NNS	O
1â3	1â3	NNP	O
acted	act	VBD	O
as	as	IN	O
true	true	JJ	O
inhibitors	inhibitor	NNS	O
,	,	,	O
we	-PRON-	PRP	O
postulated	postulate	VBD	O
that	that	IN	O
Î±-aminonitriles	î±-aminonitrile	NNS	O
in	in	IN	O
general	general	JJ	O
may	may	MD	O
act	act	VB	O
as	as	IN	O
suicide	suicide	NN	O
in	in	IN	O
situ	situ	JJ	O
donors	donor	NNS	O
of	of	IN	O
CN-	cn-	NN	O
anion	anion	NN	O
and	and	CC	O
thus	thus	RB	O
hCA	hCA	VBZ	O
inhibition	inhibition	NN	O
in	in	IN	O
general	general	JJ	O
can	can	MD	O
be	be	VB	O
expected	expect	VBN	O
from	from	IN	O
any	any	DT	O
representatives	representative	NNS	O
of	of	IN	O
this	this	DT	O
chemotype	chemotype	NN	O
with	with	IN	O
sufficient	sufficient	JJ	O
complementarity	complementarity	NN	O
to	to	IN	O
the	the	DT	O
enzymeâs	enzymeâs	NNP	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
verify	verify	VB	O
this	this	DT	O
hypothesis	hypothesis	NN	O
and	and	CC	O
also	also	RB	O
to	to	TO	O
discover	discover	VB	O
more	more	RBR	O
potent	potent	JJ	O
inhibitors	inhibitor	NNS	O
belonging	belong	VBG	O
to	to	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
to	to	TO	O
establish	establish	VB	O
structure	structure	NN	O
-	-	HYPH	O
activity	activity	NN	O
relationships	relationship	NNS	O
,	,	,	O
we	-PRON-	PRP	O
undertook	undertake	VBD	O
more	more	RBR	O
focussed	focussed	JJ	O
screening	screening	NN	O
of	of	IN	O
800	800	CD	O
publicly	publicly	RB	O
available	available	JJ	O
Î±-aminonitriles	î±-aminonitrile	NNS	O
selected	select	VBN	O
from	from	IN	O
the	the	DT	O
Enamine	Enamine	NNP	O
Ltd.	Ltd.	NNP	O
screening	screening	NN	O
collection	collection	NN	B
.	.	.	O

This	this	DT	O
led	lead	VBD	O
,	,	,	O
after	after	IN	O
subsequent	subsequent	JJ	O
biochemical	biochemical	JJ	O
testing	testing	NN	O
of	of	IN	O
the	the	DT	O
strongest	strong	JJS	O
âthermal	âthermal	JJ	O
shiftersâ	shiftersâ	NN	O
,	,	,	O
to	to	IN	O
the	the	DT	O
discovery	discovery	NN	O
of	of	IN	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
submicromolar	submicromolar	JJ	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
hCA	hca	CD	O
II	II	NNP	O
,	,	,	O
an	an	DT	O
established	establish	VBN	O
target	target	NN	O
for	for	IN	O
glaucoma	glaucoma	NN	O
and	and	CC	O
diuretic	diuretic	JJ	O
drugs	drug	NNS	B
.	.	.	O

Herein	Herein	NNP	O
,	,	,	O
we	-PRON-	PRP	O
present	present	VBP	O
the	the	DT	O
results	result	NNS	O
obtained	obtain	VBN	O
in	in	IN	O
the	the	DT	O
course	course	NN	O
of	of	IN	O
these	these	DT	O
efforts	effort	NNS	O
.	.	.	O

The	the	DT	O
800	800	CD	O
Î±-aminonitriles	î±-aminonitrile	NNS	O
for	for	IN	O
the	the	DT	O
follow	follow	NN	O
-	-	HYPH	O
up	up	RP	O
DSF	DSF	NNP	O
screening	screening	NN	O
were	be	VBD	O
selected	select	VBN	O
by	by	IN	O
substructure	substructure	NN	O
search	search	NN	O
and	and	CC	O
obtained	obtain	VBD	O
directly	directly	RB	O
from	from	IN	O
the	the	DT	O
Enamine	Enamine	NNP	O
screening	screening	NN	O
collection	collection	NN	B
.	.	.	O

Their	-PRON-	PRP$	O
identity	identity	NN	O
and	and	CC	O
purity	purity	NN	O
was	be	VBD	O
confirmed	confirm	VBN	O
by	by	IN	O
1H	1h	JJ	O
NMR	NMR	NNP	O
spectroscopy	spectroscopy	NN	O
prior	prior	RB	O
to	to	IN	O
biochemical	biochemical	JJ	O
testing	testing	NN	O
in	in	IN	O
CA	CA	NNP	O
inhibition	inhibition	NN	O
assay	assay	NN	O
.	.	.	O

Thermal	thermal	JJ	O
shift	shift	NN	O
assay	assay	NN	O
was	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
using	use	VBG	O
ViiAâ¢	ViiAâ¢	NNP	O
7	7	CD	O
Real	real	JJ	O
-	-	HYPH	O
Time	time	NN	O
PCR	PCR	NNP	O
System	System	NNP	O
equipped	equip	VBN	O
with	with	IN	O
384-well	384-well	CD	O
block	block	NN	O
.	.	.	O

The	the	DT	O
TSA	TSA	NNP	O
procedure	procedure	NN	O
was	be	VBD	O
adopted	adopt	VBN	O
from	from	IN	O
the	the	DT	O
literature	literature	NN	B
and	and	CC	O
was	be	VBD	O
modified	modify	VBN	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
allow	allow	VB	O
measuring	measure	VBG	O
the	the	DT	O
bCA	bca	NN	O
melting	melt	VBG	O
temperature	temperature	NN	O
on	on	IN	O
interaction	interaction	NN	O
with	with	IN	O
various	various	JJ	O
compounds	compound	NNS	O
,	,	,	O
including	include	VBG	O
the	the	DT	O
known	know	VBN	O
CA	CA	NNP	O
inhibitor	inhibitor	NN	O
azetazolamide	azetazolamide	NN	B
,	,	,	O
which	which	WDT	O
was	be	VBD	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
as	as	IN	O
a	a	DT	O
reference	reference	NN	O
bCA	bca	NN	O
binder	binder	NN	O
at	at	IN	O
10	10	CD	O
and	and	CC	O
20âÂµM	20ââµm	CD	O
concentration	concentration	NN	O
.	.	.	O

For	for	IN	O
800-compound	800-compound	CD	O
screening	screening	NN	O
,	,	,	O
the	the	DT	O
test	test	NN	O
reactions	reaction	NNS	O
were	be	VBD	O
set	set	VBN	O
up	up	RP	O
in	in	IN	O
the	the	DT	O
following	following	JJ	O
buffer	buffer	NN	O
:	:	:	O
10âmM	10âmm	CD	O
NaH2PO4	NaH2PO4	NNP	O
/	/	SYM	O
Na2HPO4	Na2HPO4	NNP	O
,	,	,	O
pH	pH	NNP	O
7.0	7.0	CD	O
,	,	,	O
10âmM	10âmm	CD	O
NaCl	NaCl	NNP	O
.	.	.	O

The	the	DT	O
total	total	JJ	O
volume	volume	NN	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
mixture	mixture	NN	O
per	per	IN	O
well	well	NN	O
was	be	VBD	O
10âÂµL.	10ââµl.	CD	O
Carbonic	Carbonic	NNP	O
anhydrase	anhydrase	NN	O
in	in	IN	O
300âÂµg	300ââµg	CD	O
/	/	SYM	O
mL	mL	NNP	O
concentration	concentration	NN	O
was	be	VBD	O
pre	pre	VBN	O
-	-	VBN	O
mixed	mixed	JJ	O
with	with	IN	O
environment	environment	NN	O
-	-	HYPH	O
sensitive	sensitive	JJ	O
SYPRO	SYPRO	NNP	O
orange	orange	NN	O
dye	dye	NN	O
at	at	IN	O
final	final	JJ	O
concentration	concentration	NN	O
in	in	IN	O
the	the	DT	O
reaction	reaction	NN	O
of	of	IN	O
10	10	CD	O
Ã	Ã	NNS	O
,	,	,	O
with	with	IN	O
regard	regard	NN	O
to	to	IN	O
the	the	DT	O
stock	stock	NN	O
concentration	concentration	NN	O
stated	state	VBN	O
by	by	IN	O
the	the	DT	O
vendor	vendor	NN	O
.	.	.	O

The	the	DT	O
mixtures	mixture	NNS	O
were	be	VBD	O
pre	pre	VBN	O
-	-	VBN	O
incubated	incubate	VBN	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	,	O
C	C	NNP	O
with	with	IN	O
20âÂµM	20ââµm	CD	O
concentrations	concentration	NNS	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
,	,	,	O
placed	place	VBN	O
into	into	IN	O
MicroAmpÂ	MicroAmpÂ	NNP	O
®	®	NNP	O
Optical	optical	JJ	O
384-Well	384-Well	NNP	O
Reaction	Reaction	NNP	O
Plate	Plate	NNP	O
.	.	.	O

The	the	DT	O
reaction	reaction	NN	O
mixture	mixture	NN	O
was	be	VBD	O
kept	keep	VBN	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
for	for	IN	O
15âmin	15âmin	NNP	O
to	to	TO	O
ensure	ensure	VB	O
full	full	JJ	O
protein	protein	NN	O
-	-	HYPH	O
compound	compound	NN	O
interactions	interaction	NNS	O
.	.	.	O

The	the	DT	O
temperature	temperature	NN	O
was	be	VBD	O
raised	raise	VBN	O
at	at	IN	O
1.6âÂ	1.6ââ	CD	O
°	°	,	O
C	C	NNP	O
/	/	SYM	O
s	s	NNP	O
rate	rate	NN	O
to	to	IN	O
40âÂ	40ââ	CD	O
°	°	,	O
C	C	NNP	O
without	without	IN	O
signal	signal	NN	O
reading	reading	NN	O
.	.	.	O

Starting	start	VBG	O
from	from	IN	O
40âÂ	40ââ	CD	O
°	°	NNS	O
C	c	NN	O
up	up	IN	O
to	to	IN	O
85âÂ	85âÂ	NNP	O
°	°	,	O
C	C	NNP	O
the	the	DT	O
heating	heating	NN	O
rate	rate	NN	O
was	be	VBD	O
set	set	VBN	O
to	to	IN	O
0.05âÂ	0.05ââ	CD	O
°	°	,	O
C	C	NNP	O
/	/	SYM	O
s	s	NN	O
with	with	IN	O
constant	constant	JJ	O
fluorescence	fluorescence	NN	O
reading	reading	NN	O
,	,	,	O
using	use	VBG	O
470/623ânm	470/623ânm	NNP	O
filter	filter	NN	O
set	set	NN	O
.	.	.	O

The	the	DT	O
raw	raw	JJ	O
data	datum	NNS	O
of	of	IN	O
dye	dye	NNP	O
fluorescence	fluorescence	NNP	O
intensity	intensity	NN	O
change	change	NN	O
upon	upon	IN	O
melting	melt	VBG	O
of	of	IN	O
the	the	DT	O
protein	protein	NN	O
were	be	VBD	O
obtained	obtain	VBN	O
from	from	IN	O
the	the	DT	O
instrument	instrument	NN	O
ViiA	ViiA	NNP	O
7	7	CD	O
RUO	ruo	NN	O
software	software	NN	O
.	.	.	O

Further	further	JJ	O
data	datum	NNS	O
processing	processing	NN	O
and	and	CC	O
visualisation	visualisation	NN	O
was	be	VBD	O
performed	perform	VBN	O
by	by	IN	O
custom	custom	RB	O
-	-	HYPH	O
made	make	VBD	O
Microsoft	Microsoft	NNP	O
Excel	Excel	NNP	O
scripts	script	NNS	O
.	.	.	O

The	the	DT	O
peak	peak	NN	O
of	of	IN	O
the	the	DT	O
first	first	JJ	O
derivative	derivative	NN	O
for	for	IN	O
the	the	DT	O
fluorescence	fluorescence	NN	O
curve	curve	NN	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
define	define	VB	O
melting	melt	VBG	O
temperature	temperature	NN	O
Tm	Tm	NNP	O
.	.	.	O

Tm	Tm	NNP	O
for	for	IN	O
DMSO	DMSO	NNP	O
control	control	NN	O
wells	well	NNS	O
,	,	,	O
having	have	VBG	O
only	only	RB	O
protein	protein	NN	O
,	,	,	O
dye	dye	NN	O
and	and	CC	O
1	1	CD	O
%	%	NN	O
DMSO	DMSO	NNS	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
To	to	NN	O
to	to	TO	O
determine	determine	VB	O
melting	melt	VBG	O
temperature	temperature	NN	O
shifts	shift	NNS	O
ÎTm	ÎTm	NNP	O
.	.	.	O

All	all	DT	O
measurements	measurement	NNS	O
were	be	VBD	O
made	make	VBN	O
in	in	IN	O
quadruplicates	quadruplicate	NNS	O
.	.	.	O

An	an	DT	O
Applied	Applied	NNP	O
Photophysics	Photophysics	NNPS	O
stopped	stop	VBD	O
-	-	HYPH	O
flow	flow	NN	O
instrument	instrument	NN	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
assaying	assay	VBG	O
the	the	DT	O
CA	CA	NNP	O
catalysed	catalyse	VBD	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
activity	activity	NN	B
.	.	.	O

Phenol	Phenol	NNP	O
red	red	JJ	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
of	of	IN	O
0.2âmM	0.2âmm	NN	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
an	an	DT	O
indicator	indicator	NN	O
,	,	,	O
working	work	VBG	O
at	at	IN	O
the	the	DT	O
absorbance	absorbance	NN	O
maximum	maximum	NN	O
of	of	IN	O
557ânm	557ânm	CD	O
,	,	,	O
with	with	IN	O
20âmM	20âmm	CD	O
Hepes	Hepes	NNPS	O
as	as	IN	O
a	a	DT	O
buffer	buffer	NN	O
,	,	,	O
and	and	CC	O
20âmM	20âmm	CD	O
Na2SO4	Na2SO4	NNP	O
,	,	,	O
following	follow	VBG	O
the	the	DT	O
initial	initial	JJ	O
rates	rate	NNS	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
-	-	HYPH	O
catalysed	catalyse	VBN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	O
for	for	IN	O
a	a	DT	O
period	period	NN	O
of	of	IN	O
10â100âs	10â100âs	CD	O
.	.	.	O

The	the	DT	O
CO2	CO2	NNP	O
concentrations	concentration	NNS	O
ranged	range	VBD	O
from	from	IN	O
1.7	1.7	CD	O
to	to	TO	O
17âmM	17âmm	CD	O
for	for	IN	O
the	the	DT	O
determination	determination	NN	O
of	of	IN	O
the	the	DT	O
kinetic	kinetic	JJ	O
parameters	parameter	NNS	O
and	and	CC	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
.	.	.	O

For	for	IN	O
each	each	DT	O
inhibitor	inhibitor	NN	O
at	at	IN	O
least	least	JJS	O
six	six	CD	O
traces	trace	NNS	O
of	of	IN	O
the	the	DT	O
initial	initial	JJ	O
5â10	5â10	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
have	have	VBP	O
been	be	VBN	O
used	use	VBN	O
for	for	IN	O
determining	determine	VBG	O
the	the	DT	O
initial	initial	JJ	O
velocity	velocity	NN	O
.	.	.	O

The	the	DT	O
non	non	JJ	O
-	-	JJ	O
catalysed	catalysed	JJ	O
rates	rate	NNS	O
were	be	VBD	O
determined	determine	VBN	O
in	in	IN	O
the	the	DT	O
same	same	JJ	O
manner	manner	NN	O
and	and	CC	O
subtracted	subtract	VBD	O
from	from	IN	O
the	the	DT	O
total	total	JJ	O
observed	observed	JJ	O
rates	rate	NNS	O
.	.	.	O

Stock	stock	NN	O
solutions	solution	NNS	O
of	of	IN	O
inhibitor	inhibitor	NN	O
0.1âmM	0.1âmm	CD	O
were	be	VBD	O
prepared	prepare	VBN	O
in	in	IN	O
distilled	distil	VBN	O
-	-	HYPH	O
deionized	deionize	VBN	O
water	water	NN	O
and	and	CC	O
dilutions	dilution	NNS	O
up	up	RB	O
to	to	IN	O
0.01ânM	0.01ânm	NN	O
were	be	VBD	O
done	do	VBN	O
thereafter	thereafter	RB	O
with	with	IN	O
the	the	DT	O
assay	assay	NN	O
buffer	buffer	NN	O
.	.	.	O

Inhibitor	inhibitor	NN	O
and	and	CC	O
enzyme	enzyme	NNS	O
solutions	solution	NNS	O
were	be	VBD	O
combined	combine	VBN	O
and	and	CC	O
pre	pre	VBN	O
-	-	VBN	O
incubated	incubate	VBD	O
for	for	IN	O
15âmin	15âmin	CD	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
prior	prior	RB	O
to	to	IN	O
running	run	VBG	O
the	the	DT	O
assay	assay	NN	O
,	,	,	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
allow	allow	VB	O
for	for	IN	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
the	the	DT	O
ezymeâinhibitor	ezymeâinhibitor	NN	O
complex	complex	NN	O
.	.	.	O

The	the	DT	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
were	be	VBD	O
obtained	obtain	VBN	O
by	by	IN	O
non	non	JJ	O
-	-	JJ	O
linear	linear	JJ	O
least	least	JJS	O
-	-	HYPH	O
squares	square	NNS	O
methods	method	NNS	O
using	use	VBG	O
PRISM	PRISM	NNP	O
3	3	CD	O
and	and	CC	O
the	the	DT	O
Cheng	Cheng	NNP	O
-	-	HYPH	O
Prusoff	Prusoff	NNP	O
equation	equation	NN	O
,	,	,	O
as	as	IN	O
reported	report	VBN	O
earlier	early	JJR	B
,	,	,	O
and	and	CC	O
represent	represent	VB	O
the	the	DT	O
mean	mean	NN	O
from	from	IN	O
at	at	RB	O
least	least	RBS	O
three	three	CD	O
different	different	JJ	O
determinations	determination	NNS	O
.	.	.	O

Recombinant	recombinant	JJ	O
hCA	hca	NN	O
II	II	NNP	O
was	be	VBD	O
obtained	obtain	VBN	O
in	in	IN	O
-	-	HYPH	O
house	house	NN	O
as	as	IN	O
reported	report	VBN	O
earlier	early	JJR	B
.	.	.	O

Considering	consider	VBG	O
that	that	DT	O
amino	amino	JJ	O
acetonitrile	acetonitrile	NNP	O
moiety	moiety	NNP	O
characteristic	characteristic	JJ	O
of	of	IN	O
the	the	DT	O
Strecker	Strecker	NNP	O
-	-	HYPH	O
type	type	NN	O
Î±-aminonitrile	î±-aminonitrile	NN	O
chemotype	chemotype	NN	O
was	be	VBD	O
postulated	postulate	VBN	O
as	as	IN	O
the	the	DT	O
pharmacophore	pharmacophore	NN	O
for	for	IN	O
the	the	DT	O
recently	recently	RB	O
discovered	discover	VBN	B
class	class	NN	O
of	of	IN	O
carbonic	carbonic	NNP	O
anhydrase	anhydrase	NNP	O
inhibitors	inhibitor	NNS	O
,	,	,	O
we	-PRON-	PRP	O
selected	select	VBD	O
800	800	CD	O
compounds	compound	NNS	O
featuring	feature	VBG	O
this	this	DT	O
motif	motif	NN	O
from	from	IN	O
the	the	DT	O
Enamine	Enamine	NNP	O
,	,	,	O
Ltd.	Ltd.	NNP	O
Screening	screen	VBG	O
Collection	Collection	NNP	B
and	and	CC	O
screened	screen	VBD	O
this	this	DT	O
set	set	NN	O
at	at	IN	O
20âÂµM	20ââµm	CD	O
concentration	concentration	NN	O
against	against	IN	O
bCA	bca	NN	O
for	for	IN	O
the	the	DT	O
ability	ability	NN	O
to	to	TO	O
shift	shift	VB	O
the	the	DT	O
enzymeâs	enzymeâs	NNP	O
melting	melt	VBG	O
temperature	temperature	NN	O
using	use	VBG	O
acetazolamide	acetazolamide	JJ	B
as	as	IN	O
the	the	DT	O
positive	positive	JJ	O
comparator	comparator	NN	O
producing	produce	VBG	O
aâ>â5âÂ	aâ>â5âÂ	NNP	O
°	°	NNP	O
C	C	NNP	O
shift	shift	NN	O
in	in	IN	O
bCA	bca	CD	O
Tm	Tm	NNP	B
.	.	.	O

As	as	IN	O
it	-PRON-	PRP	O
follows	follow	VBZ	O
from	from	IN	O
the	the	DT	O
graphical	graphical	JJ	O
representation	representation	NN	O
of	of	IN	O
the	the	DT	O
TSA	TSA	NNP	O
screening	screening	NN	O
data	datum	NNS	O
obtained	obtain	VBN	O
for	for	IN	O
the	the	DT	O
800	800	CD	O
compounds	compound	NNS	O
,	,	,	O
none	none	NN	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
produced	produce	VBD	O
an	an	DT	O
equally	equally	RB	O
strong	strong	JJ	O
thermal	thermal	JJ	O
shift	shift	NN	O
compared	compare	VBN	O
to	to	IN	O
AZ	AZ	NNP	O
.	.	.	O

However	however	RB	O
,	,	,	O
quite	quite	PDT	O
a	a	DT	O
few	few	JJ	O
compounds	compound	NNS	O
populated	populate	VBD	O
the	the	DT	O
>	>	XX	O
1.0âÂ	1.0ââ	CD	O
°	°	,	O
C	c	NN	O
area	area	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
select	select	VB	O
compounds	compound	NNS	O
from	from	IN	O
this	this	DT	O
subset	subset	NN	O
of	of	IN	O
âstronger	âstrong	JJR	O
shiftersâ	shiftersâ	NNP	O
for	for	IN	O
subsequent	subsequent	JJ	O
biochemical	biochemical	JJ	O
testing	testing	NN	O
of	of	IN	O
carbonic	carbonic	NNP	O
anhydrase	anhydrase	NN	O
inhibition	inhibition	NN	O
,	,	,	O
the	the	DT	O
value	value	NN	O
of	of	IN	O
the	the	DT	O
thermal	thermal	JJ	O
shift	shift	NN	O
ÎTm	ÎTm	NNP	O
,	,	,	O
Â	Â	NNP	O
°	°	,	O
C	C	NNP	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
the	the	DT	O
quality	quality	NN	O
of	of	IN	O
the	the	DT	O
melting	melt	VBG	O
curve	curve	NN	O
obtained	obtain	VBN	O
were	be	VBD	O
taken	take	VBN	O
into	into	IN	O
account	account	NN	O
.	.	.	O

With	with	IN	O
these	these	DT	O
two	two	CD	O
criteria	criterion	NNS	O
,	,	,	O
a	a	DT	O
total	total	NN	O
of	of	IN	O
47	47	CD	O
compounds	compound	NNS	O
were	be	VBD	O
selected	select	VBN	O
and	and	CC	O
tested	test	VBN	O
in	in	IN	O
stopped	stop	VBN	O
-	-	HYPH	O
flow	flow	NN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
assay	assay	NN	O
for	for	IN	O
their	-PRON-	PRP$	O
ability	ability	NN	O
to	to	TO	O
inhibit	inhibit	VB	O
hCA	hCA	NNP	O
II	II	NNP	O
.	.	.	O

The	the	DT	O
Ki	Ki	NNP	O
values	value	NNS	O
presented	present	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
clearly	clearly	RB	O
demonstrate	demonstrate	VB	O
that	that	IN	O
for	for	IN	O
a	a	DT	O
substantial	substantial	JJ	O
number	number	NN	O
of	of	IN	O
compounds	compound	NNS	O
,	,	,	O
the	the	DT	O
effect	effect	NN	O
on	on	IN	O
the	the	DT	O
enzymeâs	enzymeâs	NNP	O
melting	melting	NN	O
point	point	NN	O
determined	determine	VBN	O
by	by	IN	O
TSA	TSA	NNP	O
,	,	,	O
did	do	VBD	O
not	not	RB	O
translate	translate	VB	O
into	into	IN	O
potent	potent	JJ	O
inhibition	inhibition	NN	O
of	of	IN	O
hCA	hca	CD	O
II	ii	CD	O
.	.	.	O

Thermal	thermal	JJ	O
shift	shift	NN	O
ÎTm	ÎTm	NNP	O
,	,	,	O
Â	Â	NNP	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
the	the	DT	O
800	800	CD	O
Î±-aminonitriles	î±-aminonitrile	NNS	O
screened	screen	VBN	O
in	in	IN	O
DSF	DSF	NNP	O
assay.hCA	assay.hca	ADD	O
II	ii	CD	O
inhibition	inhibition	NN	O
data	datum	NNS	O
of	of	IN	O
48	48	CD	O
compounds	compound	NNS	O
selected	select	VBN	O
from	from	IN	O
the	the	DT	O
initial	initial	JJ	O
800-compound	800-compound	CD	O
screening	screening	NN	O
set	set	VBN	O
based	base	VBN	O
on	on	IN	O
their	-PRON-	PRP$	O
bCA	bCA	VBN	O
thermal	thermal	JJ	O
shift	shift	NN	O
ÎTm	ÎTm	NNP	O
,	,	,	O
Â	Â	NNP	O
°	°	,	O
C	C	NNP	O
values	value	NNS	O
.	.	.	O

*	*	NFP	O
Mean	Mean	NNP	O
Ki	Ki	NNP	O
values	value	NNS	O
from	from	IN	O
three	three	CD	O
different	different	JJ	O
stopped	stop	VBN	O
-	-	HYPH	O
flow	flow	NN	O
assays	assay	NNS	O
errors	error	NNS	O
were	be	VBD	O
in	in	IN	O
the	the	DT	O
range	range	NN	O
of	of	IN	O
Â±5â10	â±5â10	CC	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reported	report	VBN	O
values	value	NNS	O
.	.	.	O

A	a	DT	O
substantial	substantial	JJ	O
number	number	NN	O
of	of	IN	O
TSA	TSA	NNP	O
hits	hit	NNS	O
displayed	display	VBD	O
biochemical	biochemical	NNP	O
hCA	hCA	NNP	O
II	ii	CD	O
inhibition	inhibition	NN	O
in	in	IN	O
the	the	DT	O
same	same	JJ	O
single	single	JJ	O
-	-	HYPH	O
digit	digit	NN	O
micromolar	micromolar	JJ	O
Ki	Ki	NNP	O
range	range	NN	O
as	as	IN	O
the	the	DT	O
initial	initial	JJ	O
hits	hit	NNS	O
1â3	1â3	CD	O
.	.	.	O

Reassuringly	reassuringly	RB	O
,	,	,	O
however	however	RB	O
,	,	,	O
seven	seven	CD	O
compounds	compound	NNS	O
displayed	display	VBD	O
Ki	Ki	NNP	O
values	value	NNS	O
in	in	IN	O
the	the	DT	O
submicromolar	submicromolar	JJ	O
range	range	NN	O
,	,	,	O
which	which	WDT	O
represented	represent	VBD	O
a	a	DT	O
10-fold	10-fold	CD	O
improvement	improvement	NN	O
compared	compare	VBN	O
to	to	IN	O
inhibitory	inhibitory	JJ	O
potency	potency	NN	O
of	of	IN	O
1â3	1â3	NNP	O
towards	toward	NNS	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
these	these	DT	O
compounds	compound	NNS	O
,	,	,	O
while	while	IN	O
belonging	belong	VBG	O
to	to	IN	O
the	the	DT	O
general	general	JJ	O
Strecker	Strecker	NNP	O
Î±-aminonitrile	Î±-aminonitrile	NNP	O
class	class	NN	O
,	,	,	O
turned	turn	VBD	O
out	out	RP	O
to	to	TO	O
be	be	VB	O
structurally	structurally	RB	O
distinct	distinct	JJ	O
from	from	IN	O
the	the	DT	O
initial	initial	JJ	O
hits	hit	NNS	O
1â3	1â3	JJ	O
as	as	IN	O
they	-PRON-	PRP	O
all	all	DT	O
are	be	VBP	O
based	base	VBN	O
on	on	IN	O
a	a	DT	O
new	new	JJ	O
N	N	NNP	O
-	-	HYPH	O
piperazine	piperazine	NN	O
scaffold	scaffold	NN	O
.	.	.	O

Most	Most	JJS	O
potent	potent	JJ	O
,	,	,	O
N	N	NNP	O
-	-	HYPH	O
piperazine	piperazine	NN	O
hCA	hca	CD	O
II	II	NNP	O
inhibitors	inhibitor	NNS	O
discovered	discover	VBN	O
in	in	IN	O
the	the	DT	O
course	course	NN	O
of	of	IN	O
this	this	DT	O
study	study	NN	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
also	also	RB	O
evident	evident	JJ	O
that	that	IN	O
while	while	IN	O
all	all	DT	O
frontrunner	frontrunner	NN	O
compounds	compound	NNS	O
16â18	16â18	CD	O
,	,	,	O
30â32	30â32	CD	O
and	and	CC	O
50	50	CD	O
bear	bear	VBP	O
a	a	DT	O
hydrophobic	hydrophobic	JJ	O
aliphatic	aliphatic	JJ	O
or	or	CC	O
aromatic	aromatic	JJ	O
substituent	substituent	NN	O
on	on	IN	O
the	the	DT	O
same	same	JJ	O
carbon	carbon	NN	O
atom	atom	NN	O
as	as	IN	O
the	the	DT	O
cyano	cyano	NNP	O
group	group	NN	O
,	,	,	O
the	the	DT	O
N4	n4	JJ	O
position	position	NN	O
of	of	IN	O
the	the	DT	O
piperazine	piperazine	NN	O
ring	ring	NN	O
is	be	VBZ	O
substituted	substitute	VBN	O
with	with	IN	O
a	a	DT	O
relatively	relatively	RB	O
polar	polar	JJ	O
group	group	NN	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
examination	examination	NN	O
of	of	IN	O
the	the	DT	O
SAR	SAR	NNP	O
information	information	NN	O
contained	contain	VBN	O
in	in	IN	O
the	the	DT	O
total	total	JJ	O
TSA	TSA	NNP	O
screening	screening	NN	O
data	datum	NNS	O
,	,	,	O
reveals	reveal	VBZ	O
that	that	IN	O
hydrophobic	hydrophobic	JJ	O
groups	group	NNS	O
at	at	IN	O
N4	N4	NNP	O
reduce	reduce	VBP	O
the	the	DT	O
compoundâs	compoundâs	CD	O
affinity	affinity	NN	O
to	to	IN	O
the	the	DT	O
target	target	NN	O
as	as	RB	O
indirectly	indirectly	RB	O
measured	measure	VBN	O
by	by	IN	O
ÎTm	ÎTm	NNP	O
.	.	.	O

Such	such	PDT	O
an	an	DT	O
active	active	JJ	O
chemotype	chemotype	NN	O
topology	topology	NN	O
appear	appear	VBP	O
to	to	TO	O
be	be	VB	O
in	in	IN	O
line	line	NN	O
with	with	IN	O
the	the	DT	O
known	know	VBN	O
distinct	distinct	JJ	O
architecture	architecture	NN	O
of	of	IN	O
the	the	DT	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
active	active	JJ	O
site	site	NN	O
where	where	WRB	O
two	two	CD	O
halves	half	NNS	O
â	â	NNP	O
hydrophobic	hydrophobic	NN	O
and	and	CC	O
hydrophilic	hydrophilic	NN	O
are	be	VBP	O
clearly	clearly	RB	O
delineated	delineate	VBN	B
.	.	.	O

Considering	consider	VBG	O
the	the	DT	O
fact	fact	NN	O
that	that	IN	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
exert	exert	VB	O
its	-PRON-	PRP$	O
inhibitory	inhibitory	JJ	O
potency	potency	NN	O
,	,	,	O
the	the	DT	O
inhibitorâs	inhibitorâs	CD	O
molecule	molecule	NN	O
must	must	MD	O
have	have	VB	O
complementarity	complementarity	NN	O
to	to	IN	O
its	-PRON-	PRP$	O
active	active	JJ	O
site	site	NN	O
,	,	,	O
such	such	JJ	O
hydrophilic	hydrophilic	JJ	O
/	/	SYM	O
hydrophobic	hydrophobic	JJ	O
dichotomy	dichotomy	NN	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
inhibitors	inhibitor	NNS	O
matches	match	VBZ	O
that	that	DT	O
of	of	IN	O
the	the	DT	O
hCA	hca	NN	O
II	II	NNP	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

Preliminary	preliminary	JJ	O
SAR	SAR	NNP	O
generalisations	generalisation	NNS	O
and	and	CC	O
possible	possible	JJ	O
binding	binding	JJ	O
mode	mode	NN	O
of	of	IN	O
N	n	NN	O
-	-	HYPH	O
piperazines	piperazine	NNS	O
.	.	.	O

Testing	testing	NN	O
of	of	IN	O
an	an	DT	O
expanded	expand	VBN	O
,	,	,	O
800-compound	800-compound	CD	O
set	set	NN	O
of	of	IN	O
analogues	analogue	NNS	O
of	of	IN	O
the	the	DT	O
earlier	early	RBR	O
described	describe	VBN	O
Strecker	Strecker	NNP	O
-	-	HYPH	O
type	type	NN	O
Î±-aminonitriles	î±-aminonitrile	NNS	O
in	in	IN	O
thermal	thermal	JJ	O
shift	shift	NN	O
assay	assay	NN	O
against	against	IN	O
bovine	bovine	NNP	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
led	lead	VBD	O
not	not	RB	O
only	only	RB	O
to	to	IN	O
further	further	JJ	O
validation	validation	NN	O
of	of	IN	O
this	this	DT	O
new	new	JJ	O
class	class	NN	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
but	but	CC	O
also	also	RB	O
to	to	IN	O
refinement	refinement	NN	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
chemotype	chemotype	NN	O
,	,	,	O
which	which	WDT	O
became	become	VBD	O
possible	possible	JJ	O
after	after	IN	O
biochemical	biochemical	JJ	O
testing	testing	NN	O
of	of	IN	O
47	47	CD	O
selected	select	VBN	O
TSA	TSA	NNP	O
hits	hit	NNS	O
for	for	IN	O
hCA	hca	CD	O
II	ii	CD	O
inhibition	inhibition	NN	O
in	in	IN	O
stopped	stop	VBN	O
-	-	HYPH	O
flow	flow	NN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
assay	assay	NN	O
.	.	.	O

The	the	DT	O
active	active	JJ	O
chemotype	chemotype	NN	O
can	can	MD	O
be	be	VB	O
defined	define	VBN	O
as	as	IN	O
N1-piperazine	n1-piperazine	NN	O
bearing	bear	VBG	O
two	two	CD	O
other	other	JJ	O
substituents	substituent	NNS	O
on	on	IN	O
the	the	DT	O
opposite	opposite	JJ	O
sides	side	NNS	O
of	of	IN	O
the	the	DT	O
piperazine	piperazine	NN	O
core	core	NN	O
.	.	.	O

Such	such	PDT	O
a	a	DT	O
dichotomy	dichotomy	NN	O
of	of	IN	O
the	the	DT	O
newly	newly	RB	O
identified	identify	VBN	O
pharmacophore	pharmacophore	NN	O
appears	appear	VBZ	O
to	to	TO	O
be	be	VB	O
in	in	IN	O
line	line	NN	O
with	with	IN	O
the	the	DT	O
known	know	VBN	O
bipolar	bipolar	JJ	O
character	character	NN	O
of	of	IN	O
the	the	DT	O
enzymeâs	enzymeâs	NNP	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

Further	further	JJ	O
studies	study	NNS	O
are	be	VBP	O
underway	underway	JJ	O
to	to	TO	O
investigate	investigate	VB	O
the	the	DT	O
validity	validity	NN	O
of	of	IN	O
this	this	DT	O
hypothesis	hypothesis	NN	O
.	.	.	O

